Hyphens Pharma provides better quality of life
Solidifying its position as the gateway to the growing pharmaceutical industry in Southeast Asia, Hyphens Pharma introduces innovative global health care products in the region as a leading speciality pharmaceutical company.
With Southeast Asia's combined pharmaceutical market value projected to reach US$69.1 billion by 2016, Hyphens is scaling up operations in its Singapore headquarters and offices in Indonesia, Malaysia, Vietnam and the Philippines.
Hyphens bridges medical and industry knowledge to ensure a product's success in the market. The company markets mostly biomedical products in therapeutic fields such as allergies, gastroenterology, obstetrics and radiology.
"We work with large multinational and pharmaceutical companies to bring innovative products to Asia," says Hyphens managing director Lim See Wah. "A product that is marketed under the Hyphens brand bears a mark of trust. It is a certification of quality."
While Hyphens traditionally works with leading manufacturers from Europe, it is actively seeking innovation originating from China, South Korea and Japan.
Hyphens keeps strong ties with key health professionals and opinion leaders to expertly market products from leading medical manufacturers such as Bausch + Lomb, Guerbet, Laboratoires Expanscience and Biosensors. It creates communication platforms between its medical representatives and doctors to impart a product's benefits effectively.
Hyphens also promotes optimal care for patients with its holistic medical views. "Close interaction with doctors and clients gives us valuable insight on the different health care systems and markets," Lim says. "We partner with doctors to bring benefits to the patients."
Aside from promoting patient care, Hyphens has strong regulatory capability in Singapore and in the countries where it operates. This capability allows the company to obtain product registration approval successfully and quickly, paving the way for the rapid launch of products.
"We provide clients with strong marketing and advisory support," Lim says.
"As we scale up, we look forward to working with innovative and expert partners. We are the clients' health care partner in Asia."